Bosh sahifaRGLS • NASDAQ
add
Regulus Therapeutics Inc
1,47 $
Seans yopilganidan keyin:(2,72%)+0,040
1,51 $
Yopilgan:22-noy, 17:20:00 (GMT-5) · USD · NASDAQ · Ogohlantirish
Yopilish kursi
1,40 $
Kunlik diapazon
1,37 $ - 1,48 $
Yillik diapazon
1,08 $ - 3,79 $
Bozor kapitalizatsiyasi
96,29 mln USD
Oʻrtacha hajm
407,53 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | — | — |
Joriy xarajat | 14,19 mln | 81,62% |
Sof foyda | -14,06 mln | -79,73% |
Sof foyda marjasi | — | — |
Har bir ulushga tushum | -0,21 | 47,50% |
EBITDA | -15,12 mln | -87,38% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 87,31 mln | 183,64% |
Jami aktivlari | 93,76 mln | 148,40% |
Jami passivlari | 6,96 mln | -26,67% |
Umumiy kapital | 86,80 mln | — |
Tarqatilgan aksiyalar | 65,50 mln | — |
Narxi/balansdagi bahosi | 1,05 | — |
Aktivlardan daromad | -38,43% | — |
Kapitaldan daromad | -40,53% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -14,06 mln | -79,73% |
Operatsiyalardan naqd pul | -9,45 mln | -50,53% |
Sarmoyadan naqd pul | 18,64 mln | 442,72% |
Moliyadan naqd pul | 56,00 ming | -80,49% |
Naqd pulning sof oʻzgarishi | 9,25 mln | 180,94% |
Boʻsh pul | -4,32 mln | -55,64% |
Haqida
Regulus Therapeutics Inc. is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Wikipedia
Tashkil etilgan
sen 2007
Sayt
Xodimlar soni
32
